InChI=1S/C17H18ClN3O4/c1- 10(19- 9- 13- 3- 2- 8- 25- 13) 14- 15(22) 20- 17(24) 21(16(14) 23) 12- 6- 4- 11(18) 5- 7- 12/h4- 7,13,19H,2- 3,8- 9H2,1H3,(H,20,22,24) |
RGCKYJOSEHCNTI-UHFFFAOYSA-N |
CC(=C1C(=O)NC(=O)N(C1=O)C2=CC=C(C=C2)Cl)NCC3CCCO3 |
|
GABA modulator
A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act.
(via barbiturates )
|
|
GABA modulator
A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act.
(via barbiturates )
|
|
View more via ChEBI Ontology
Outgoing
|
1-(4-chlorophenyl)-5-[1-(2-oxolanylmethylamino)ethylidene]-1,3-diazinane-2,4,6-trione
(CHEBI:109059)
is a
barbiturates
(CHEBI:22693)
|
|
|